Iran plans to roll out its COVID-19 vaccine by April 20, the president of the Headquarters for Executing the Orders of Imam Khomeini said on Tuesday.
Mohammad Mokhber said Barekat Foundation, the executive subsidiary of the headquarters, is preparing the ground for the mass production of Coviran Barekat, Iran’s first coronavirus vaccine.
He said the production line for making two to three million doses of Coviran Barekat will be launched within weeks and there is a plan to increase the capacity to 12 to 14 million doses by May.
Mokhber also said the first phase in the human trial of Coviran has been successful and that the volunteers who received the jab are fine.
The vaccine was administered to three volunteers at a ceremony in Tehran in late December.
Mokhber said Barekat is ready to start the second phase of the human trial once it gets an approval from the Health Ministry.
“If this permit is issued, the work will accelerate and hopefully we will be able to start vaccination using the Iranian vaccine by April 20.”
He said Iran has received requests from other countries to obtain Coviran Barekat but noted that the priority goes to the Iranian nation.
Mokhber also said the headquarters has worked on three other coronavirus vaccines and awaits for the go-ahead to start the human trial.